In the field of influenza treatment, Sebaloxavir Marbaxil Tablets (trade name: Jikeshu), independently developed in China, marks a significant technological breakthrough, providing a new solution for global public health. As an innovative drug, it was approved for marketing by the National Medical Products Administration in July 2025. Specifically designed for adults with uncomplicated...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek